Importantly, MYC is highly pleiotropic [54] indicating that its deregulation is in close connection with all hematological malignancies, especially anaemia [55,56] which is a prominent feature of the AAT disease and also with drug resistance [56,57,58,59]. This evidence concerns the gene MYC and anemia (phenotype).